Certificate PL-26-00348 · VIP 5 mg · lot PL-2610-235 · branded for Epic Wholesalers LLC -dba-Epic Peptides Lab
VerifyCertificate page
Epic Wholesalers LLC -dba-Epic Peptides Lab
Epic Wholesalers LLC -dba-Epic Peptides Lab
Certificate of Analysis · Lot release
www.epicpeptideslab.com
Certificate no.
PL-26-00348
Verification key
K7KAUR64
Scan or enter both at
prymalab.net/testing/verify

Certificate of Analysis · Lot release · Issued for Epic Wholesalers LLC -dba-Epic Peptides Lab

VIP 5 mg

Lot PL-2610-235 · Lyophilized powder · Label claim 5 mg per vial
Tested in-house by PrymaLab
In-house analytical result,
not an independent third-party test
Lot / batch number
PL-2610-235
Date made
2026-10-08
Date of analysis
2026-10-12
Date issued
2026-10-27
Retest / expiry
2028-10-08
Units in lot / sampled
203 / 2
Storage
−20 °C, desiccated, dark
Certificate type
Lot COA, 2 pages
Compound
VIP
Vasoactive intestinal peptide (1-28) amide; aviptadil
CAS number
55556-37-1
Molecular formula
C147H238N44O42S
Theoretical mass (avg.)
3,325.80 Da
Sequence
HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2
Purity · RP-HPLC, area %
99.43%
Specification ≥ 99.0% • main peak at 15.35 min
Identity · Observed Mass
3,326.01 Da
Theoretical 3,325.80 Da • +0.21 Da (63 ppm)
Overall conclusion
PASS
Meets every specification for the tests performed
TestMethodSpecificationResultConclusion
Identity (mass)LC-MS, ESI positiveTheoretical ± 1.0 Da3,326.01 DaPASS
PurityRP-HPLC, UV 214 nm, area%≥ 99.0%99.43%PASS
Largest impurityRP-HPLC, area%≤ 1.0%0.44% (RT 16.50)PASS
Water contentKarl Fischer≤ 5.0%1.31%PASS
Bacterial endotoxinLAL, kinetic≤ 5.0 EU/mg0.356 EU/mgPASS
SterilityUSP <71>, 14-dayNo growthNo growthPASS

1HPLC chromatogram

Data file: PL-2610-235-HPLC.raw · Column C18, 150 × 4.6 mm · UV 214 nm
0.01%0.1%1%10%100%12131415161718Retention time (min) · stick height = area % (log scale)99.43% · 15.35 min0.03% †0.10% †0.44% †
Peak plot drawn from the integrated peak table (area %, log scale); it is not the instrument trace, which is retained in PL-2610-235-HPLC.raw. † Nominal reference retention time for the assigned impurity; the main-peak RT is observed in this lot.
Epic Wholesalers LLC -dba-Epic Peptides Lab
Epic Wholesalers LLC -dba-Epic Peptides Lab
Certificate of Analysis · continued
VIP 5 mg · Lot PL-2610-235 · Certificate PL-26-00348
Lot PL-2610-235
Method, peak table and approval

2HPLC method · PL-2610-235-HPLC.raw

Instrument
Waters Alliance e2695
Data System
Empower 3
Detector
UV absorbance
Detection Wavelength
214 nm
Column
C18, 150 × 4.6 mm, 3.5 µm
Mobile Phase A
0.1% TFA in water
Mobile Phase B
0.1% TFA in MeCN
Gradient
5–95% B over 25 min (linear)
Flow Rate
1.0 mL/min
Column Temperature
40 °C
Injection Volume
10 µL

3Gradient program

Time (min)% A% B
0.0955
25.0595

4Peak table

PeakRT (min)AreaArea %
113.90 †—0.03
214.70 †—0.10
315.35—99.43
416.50 †—0.44
Total—100.00
Peaks: 1 deamidation product; 2 tryptophan oxidation product; 3 main peak (VIP); 4 truncated sequence · Area % from the integrated peak table (absolute areas are not part of the lot-release export) · † nominal reference RT for the assigned impurity · Purity = main peak area ÷ total integrated area × 100, to two decimals; main peak shaded.

5Identity by mass spectrometry

Instrument
Waters SQD
Ionization / Mode
ESI, positive
Reference m/z (charge)
1109.61 (3+) · 832.46 (4+)
Deconvoluted Mass
3,326.01 Da
Theoretical Mass
3,325.80 Da
Difference
+0.21 Da (63 ppm)
Data File
PL-2610-235-MS.d
Acceptance
Within ± 1.0 Da

6Additional tests

TestPerformed byDateReport / file
Water content (Karl Fischer)PrymaLab Analytical2026-10-12—
Endotoxin (LAL, kinetic)PrymaLab Analytical2026-10-12—
Sterility (USP <71>, day-14 read-out)PrymaLab Analytical2026-10-26—
A test with no row here was not performed on this lot. Outside-laboratory reports, when used, are attached and named below.

7Review and approval

D. Reynolds
Analyst · performed the testing
Date: 2026-10-27
S. Calloway
Reviewer · checked against raw data
Date: 2026-10-27
M. Phelps
Lab Director · approved for release
Date: 2026-10-27